| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | SVP, Research And Development
1 company
Glenn Gregory M is a President, R&D at NOVAVAX INC. Recent SEC Form 4 filings include 8 buys and 6 sells.
Estimated insider holdings value: $130K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | NVAX Novavax Inc | President, R&D | Sale+OE | 55,921 | $145.20 | $8,119,860.22 | -42.7% | |
| Jun 18, 2020 | NVAX Novavax Inc | President, R&D | Sale+OE | 16,749 | $59.53 | $997,103.14 | -90.1% | |
| Jan 31, 2020 | NVAX Novavax Inc | President, R&D | Buy | 1,250 | $3.86 | $4,825.00 | +1,016% | |
| Sep 13, 2019 | NVAX Novavax Inc | President, R&D | Sell | 9,620 | $6.18 | $59,475.65 | -98.7% | |
| May 13, 2019 | NVAX Novavax Inc | President, R&D | Buy | 1,000 | $5.85 | $5,849.90 | +1.4% | |
| Jan 31, 2019 | NVAX Novavax Inc | President, R&D | Buy | 13,168 | $0.88 | $11,587.84 | +21.9% | |
| Jul 31, 2018 | NVAX Novavax Inc | President, R&D | Buy | 13,007 | $0.88 | $11,446.16 | +27.6% | |
| May 14, 2018 | NVAX Novavax Inc | President, R&D | Buy | 20,000 | $1.64 | $32,799.50 | +36.7% | |
| Jan 31, 2018 | NVAX Novavax Inc | President, R&D | Buy | 12,784 | $0.88 | $11,249.92 | +88.6% | |
| Nov 9, 2017 | NVAX Novavax Inc | President, R&D | Buy | 10,000 | $1.13 | $11,300.00 | +225.9% |